hi If you mean MRSA Methicillin Resistant Staphylococcus theres one treatment thats been shown to work well is high dose iv vitamin C 50g the other treatment is listed below cheers Ray
http://en.wikipedia.org/wiki/MRSA
Both CA-MRSA and HA-MRSA are resistant to traditional anti-staphylococcal beta-lactam antibiotics, such as cephalexin. CA-MRSA has a greater spectrum of antimicrobial susceptibility, including to sulfa drugs, tetracyclines, and clindamycin. HA-MRSA is resistant even to these antibiotics and often is susceptible only to vancomycin. Newer drugs, such as linezolid (belonging to the newer oxazolidinones class), may be effective against both CA-MRSA and HA-MRSA.
Vancomycin and teicoplanin are glycopeptide antibiotics used to treat MRSA infections.[18] Teicoplanin is a structural congener of vancomycin that has a similar activity spectrum but a longer half-life (t½).[19] Because the oral absorption of vancomycin and teicoplanin is very low, these agents must be administered intravenously to control systemic infections.[20] Treatment of MRSA infection with vancomycin can be complicated, due to its inconvenient route of administration. Moreover, many clinicians believe that the efficacy of vancomycin against MRSA is inferior to that of anti-staphylococcal beta-lactam antibiotics against MSSA.[21][22]
Several newly discovered strains of MRSA show antibiotic resistance even to vancomycin and teicoplanin. These new evolutions of the MRSA bacterium have been dubbed Vancomycin intermediate-resistant Staphylococcus aureus (VISA).[23][24] Linezolid, quinupristin/dalfopristin, daptomycin, and tigecycline are used to treat more severe infections that do not respond to glycopeptides such as vancomycin.[25] MRSA infections can be treated with oral agents, including linezolid, rifampicin+fusidic acid, rifampicin+fluoroquinolone, pristinamycin, co-trimoxazole (trimethoprim-sulfamethoxazole), doxycycline or minocycline, and clindamycin.[26]
On May 18, 2006, a report in Nature identified a new antibiotic, called platensimycin, that had demonstrated successful use against MRSA.[27][28]
An entirely different and promising approach is phage therapy (e.g., at the Eliava Institute in Georgia[29]), which has a reported efficacy against up to 95% of tested Staphylococcus isolates.[30]
It has been reported that maggot therapy to treat MRSA infection has been successful. Studies in diabetic patients reported significantly shorter treatment times than those achieved with standard treatments.[31][32][33]
On Saturday, February 14, 2009 Science News published an article on early-stage research which found that ocean-dwelling living sponges produced compounds that resensitise bacteria to antibiotics[34].
A study at the University of East London, has found that allicin, a compound found in garlic, successfully treats MRSA. [35].
Extensive studies at the University of York have found that minute quantities of silver carbonate nanoparticles show excellent antimicrobial effectiveness [36].
Chemical analyses identified a compound called ageliferin. Biofilms, communities of bacteria notoriously resistant to antibiotics, dissolved and did not re-form when treated with fragments of the ageliferin molecule.
So far, the ageliferin offshoot has, in the lab, successfully resensitized bacteria that cause whooping cough, ear infections, septicemia and food poisoning. The compound also works on Pseudomonas aeruginosa, which causes infections in wounded soldiers, and MRSA infections.